This study aims to evaluate the rate of patients submitted to pancreatic resection for pancreatic cancer, who fail to access to adjuvant therapy or do not complete adjuvant therapy. The purpose is to give an overview concerning the most frequent conditions and/or reasons associated with failure or omission of adjuvant therapy.
This prospective observational study will evaluate all patients submitted to pancreatic resection for pancreatic cancer. The rate of omission to adjuvant therapy and rate of failure of completion of adjuvant therapy will be evaluated as primary outcomes. As secondary outcomes, survival analyses will be performed to investigate whether these factors influence prognosis, that will be evaluated through a disease free survival analysis at 18-months. Epidemiological and perioperative data will be analyzed to identify conditions associated with the primary outcomes.
Study Type
OBSERVATIONAL
Enrollment
317
University of Verona Hospital
Verona, Italy
Rate of patients who fail to receive adjuvant therapy and reasons for that
The amount of patients who will not receive adjuvant therapy after pancreatic resection for malignancy (when do indication exists) will be recorded
Time frame: 6 months
Rate of patients who fail to complete adjuvant therapy and reasons for that
The amount of patients who will not complete adjuvant therapy after pancreatic resection for malignancy will be recorded
Time frame: 9 months
Disease free survival of patients enrolled
Time frame: 18 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.